🏥 治験ポータル
← 治験一覧に戻る

以前に手術を受けたI-IIA期子宮頸がん患者における化学療法の有無にかかわらず放射線療法

基本情報

NCT ID
NCT01101451
ステータス
完了
試験のフェーズ
第3相
試験タイプ
介入
目標被験者数
340
治験依頼者名
GOG Foundation

概要

This randomized phase III trial studies radiation therapy with chemotherapy to see how well they work compared to radiation therapy alone in treating patients with stage I-IIA cervical cancer who previously underwent surgery. Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving radiation therapy together with chemotherapy is more effective than radiation therapy alone in treating patients with cervical cancer.

対象疾患

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage I Cervical Cancer AJCC v6 and v7Stage IA Cervical Cancer AJCC v6 and v7Stage IB Cervical Cancer AJCC v6 and v7Stage IIA Cervical Cancer AJCC v7

介入

Cisplatin(DRUG)
External Beam Radiation Therapy(RADIATION)
Intensity-Modulated Radiation Therapy(RADIATION)
Laboratory Biomarker Analysis(OTHER)
Quality-of-Life Assessment(OTHER)
Questionnaire Administration(OTHER)

依頼者(Sponsor)

実施施設 (8)

東北大学病院

Sendai, Aoba-ku, Japan

新潟大学医歯学総合病院

Niigata, Niigata, Japan

独立行政法人国立病院機構四国がんセンター

Matsuyama, Japan

鹿児島市立病院

Kagoshima, Kagoshima-ken, Japan

近畿大学病院

Osaka, Japan

岩手医科大学附属病院

Shiwa-gun, Iwate, Japan

社会福祉法人恩賜財団済生会支部 広島県済生会 済生会呉病院

Kure, Hiroshima, Japan

静岡県立静岡がんセンター

Shizuoka, Suntou, Japan